Amyris

Jun 10, 2020

Positive First Steps Show the Promise of Psychedelic Therapies

Jun 03, 2020

Studies Into Psychedelic Drugs Reveal Significant Medical Potential

May 08, 2020

Amyris, Inc. Reports First Quarter 2020 Results

Mar 31, 2020

Amyris Scales Up in Response to High Need for Its Hand Sanitizer and Wipe Products

Mar 26, 2020

Amyris Launches Leading Hand Sanitizer and Receives Initial Positive Result for Vaccine Adjuvant

Mar 16, 2020

Amyris Provides Business Update

Mar 10, 2020

Amyris to Participate in Fireside Chat at 32nd Annual Roth Conference on March 16, 2020

Mar 09, 2020

Amyris Expands Distribution of PURECANE Baking Sweetener on Amazon -- Strong Early Sales

Mar 05, 2020

Amyris to Announce Fourth Quarter and Fiscal Year 2019 Financial Results on Thursday, March 12

Feb 26, 2020

Amyris to Present at Cowen 40th Annual Health Care Conference on March 3, 2020

Nov 11, 2019

Amyris Executes Agreements to Resolve CVI Heights Debt

Sep 27, 2019

Amyris to Host First-Half 2019 Financial Results Teleconference on Wednesday, October 2, 2019

Aug 30, 2019

Amyris to Present at H.C. Wainwright 21st Annual Global Investment Conference on September 9, 2019

Jul 19, 2019

ADL Bionatur Solutions and Amyris Expand Contract to 2020

Jun 10, 2019

Berkeley Lights, Inc. And Amyris Announce Collaboration To Speed Testing Of Microbial Strains

Dec 05, 2017

High Demand From EMEA to Boost the Global Farnesene Market | Technavio